News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Zalevsky Jonathan
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 9,703 shares
@ $0.78, valued at
$7.6k
|
|
| 05/17/2023 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 9,791 shares
@ $0.72, valued at
$7k
|
|
| 11/18/2022 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 13,460 shares
@ $3.57, valued at
$48.1k
|
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 10,912 shares
@ $10.95, valued at
$119.5k
|
|
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2021 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 40,150 shares
@ $0
Sold 20,869 shares
@ $13.16, valued at
$274.6k
|
|
| 10/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 24,141 shares
@ $22.37, valued at
$540k
|
|
| 12/22/2020 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 40,000 shares
@ $0
Granted 71,500 options
@ $18.75, valued at
$1.3M
|
|
| 11/25/2020 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 16,380 shares
@ $16.4, valued at
$268.6k
|
|
| 11/18/2020 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 29,618 shares
@ $16.93, valued at
$501.4k
|
|
| 08/19/2020 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 26,200 shares
@ $19.67, valued at
$515.4k
|
|
| 05/20/2020 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 4,558 shares
@ $22.51, valued at
$102.6k
|
|
| 02/20/2020 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Sold 4,774 shares
@ $22.35, valued at
$106.7k
|
|
| 12/16/2019 |
4
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 4 on NEKTAR THERAPEUTICS|
Txns:
| Granted 40,150 shares
@ $0
Granted 71,550 options
@ $21.79, valued at
$1.6M
Granted 20,100 options
@ $21.79, valued at
$438k
|
|
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2019 |
3
| Zalevsky Jonathan (Chief R&D Officer) has filed a Form 3 on NEKTAR THERAPEUTICS |
|
|